QS Investors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

QS Investors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,000	Closed	-$95K	–	1722
2019 Q4	$95K	Sell	4,000 -3,400	-46%	-$93.8K	﹤0.01%	1404
2019 Q3	$199K	Hold	7,400	–	–	﹤0.01%	1206
2019 Q2	$201K	Buy	+7,400	New	+$232K	﹤0.01%	1220
2018 Q4	–	Sell	-2,600	Closed	-$69K	–	1954
2018 Q3	$69K	Sell	2,600 -11	-0.4%	-$359	﹤0.01%	1457
2018 Q2	$99K	Hold	2,611	–	–	﹤0.01%	1414
2018 Q1	$85K	Hold	2,611	–	–	﹤0.01%	1405
2017 Q4	$127K	Hold	2,611	–	–	﹤0.01%	1346
2017 Q3	$141K	Hold	2,611	–	–	﹤0.01%	1348
2017 Q2	$147K	Buy	+2,611	New	+$105K	﹤0.01%	1315
2016 Q3	–	Sell	-11	Closed	-$1K	–	2000
2016 Q2	$1K	Sell	11 -11	-50%	-$272	﹤0.01%	1904
2016 Q1	$1K	Buy	22 +16	+267%	+$508	﹤0.01%	1874
2015 Q4	$1K	Buy	+6	New	+$291	﹤0.01%	1941

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

QS Investors's PTLA Position: Q1 2020 in Review

QS Investors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 4,000 shares — an estimated $95K sold.

QS Investors first reported a position in PTLA in Q4 2015 and held it in 12 quarters. The position peaked at $201K in Q2 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

QS Investors reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
QS Investors sold 4,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $95K.
QS Investors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 12 quarters.
QS Investors's Portola Pharmaceuticals, Inc. position peaked at $201K in Q2 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on QS Investors's 13F filing for Q1 2020, filed 15 May 2020.